Towa Pharmaceutical Co., Ltd. (FRA:6QC)

Towa Pharmaceutical Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 3, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	909	815	876	646	1,006	926
Market Cap Growth	-1.89%	-6.98%	35.63%	-35.82%	8.64%	-1.83%
Enterprise Value	1,942	2,015	1,890	1,544	1,447	1,443
Last Close Price	18.10	15.98	17.13	12.26	18.34	-
PE Ratio	7.65	6.95	8.84	42.38	8.53	8.61
PS Ratio	0.59	0.51	0.63	0.45	0.82	0.78
PB Ratio	0.88	0.77	0.92	0.68	1.03	1.03
P/TBV Ratio	1.16	1.05	1.36	1.11	1.74	1.18
P/FCF Ratio	-	-	-	-	12.35	41.88
P/OCF Ratio	5.48	5.64	17.41	36.67	6.13	10.01
EV/Sales Ratio	1.32	1.26	1.35	1.07	1.18	1.21
EV/EBITDA Ratio	7.88	7.52	8.68	8.95	6.62	6.17
EV/EBIT Ratio	15.15	14.03	17.48	40.43	10.53	9.40
EV/FCF Ratio	-297.87	-	-	-	17.76	65.24
Debt / Equity Ratio	1.31	1.38	1.32	1.26	1.09	0.73
Debt / EBITDA Ratio	5.30	5.45	5.80	6.94	4.89	2.79
Debt / FCF Ratio	-	-	-	-	13.12	29.53
Asset Turnover	0.58	0.58	0.57	0.60	0.57	0.65
Inventory Turnover	1.51	1.58	1.51	1.64	1.43	1.61
Quick Ratio	1.28	1.33	1.26	1.00	0.73	1.33
Current Ratio	2.80	2.81	2.72	2.33	1.45	2.67
Return on Equity (ROE)	12.18%	11.59%	11.05%	1.64%	12.79%	12.62%
Return on Assets (ROA)	3.14%	3.22%	2.75%	0.98%	4.03%	5.26%
Return on Capital (ROIC)	3.64%	3.77%	3.28%	1.18%	4.85%	6.41%
Return on Capital Employed (ROCE)	6.00%	6.10%	5.00%	1.90%	8.60%	10.30%
Earnings Yield	13.07%	14.40%	11.31%	2.36%	11.72%	11.61%
FCF Yield	-0.72%	-4.04%	-20.74%	-28.07%	8.10%	2.39%
Dividend Yield	2.73%	2.71%	2.15%	3.39%	2.30%	-
Payout Ratio	16.94%	15.55%	18.25%	140.84%	15.15%	15.52%
Buyback Yield / Dilution	-0.01%	-0.01%	0.00%	2.19%	1.86%	3.57%
Total Shareholder Return	2.71%	2.70%	2.15%	5.58%	4.16%	3.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.